Kathleen Welsh-Bohmer

Affiliations: 
Psychiatry & Behavioral Sciences Duke Medical School, Durham, NC, United States 
Google:
"Kathleen Welsh-Bohmer"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Zhou X, Zou H, Lutz MW, et al. (2024) Assessing tilavonemab efficacy in early Alzheimer's disease via longitudinal item response theory modeling. Alzheimer's & Dementia (New York, N. Y.). 10: e12471
Reese M, Wong MK, Cheong V, et al. (2024) Cognitive and cerebrospinal fluid Alzheimer's disease-related biomarker trajectories in older surgical patients and matched nonsurgical controls. Anesthesiology
Watts A, Haneline S, Welsh-Bohmer KA, et al. (2023) TOMM40 '523 Genotype Distinguishes Patterns of Cognitive Improvement for Executive Function in APOEɛ3 Homozygotes. Journal of Alzheimer's Disease : Jad
Grazia A, Altomare D, Preis L, et al. (2022) Feasibility of a standard cognitive assessment in European academic memory clinics. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Atkins AS, Kraus MS, Welch M, et al. (2022) Remote self-administration of digital cognitive tests using the Brief Assessment of Cognition: Feasibility, reliability, and sensitivity to subjective cognitive decline. Frontiers in Psychiatry. 13: 910896
Kimmel HJ, Levine DA, Whitney RT, et al. (2021) A Mixed-Methods Study of the Impact of Mild Cognitive Impairment Diagnosis on Patient and Care Partner Perception of Health Risks. Journal of Alzheimer's Disease : Jad
Shadyab AH, LaCroix AZ, Feldman HH, et al. (2021) Recruitment of a multi-site randomized controlled trial of aerobic exercise for older adults with amnestic mild cognitive impairment: The EXERT trial. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Burns DK, Alexander RC, Welsh-Bohmer KA, et al. (2021) Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial. The Lancet. Neurology. 20: 537-547
Levine DA, Galecki AT, Plassman BL, et al. (2021) The Association Between Mild Cognitive Impairment Diagnosis and Patient Treatment Preferences: a Survey of Older Adults. Journal of General Internal Medicine
Smith PJ, Mabe SM, Sherwood A, et al. (2020) Metabolic and Neurocognitive Changes Following Lifestyle Modification: Examination of Biomarkers from the ENLIGHTEN Randomized Clinical Trial. Journal of Alzheimer's Disease : Jad
See more...